Cargando…
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
Epidermal growth factor receptor (EGFR) overexpression is related to the increased aggressiveness, metastases, and poor prognosis in various cancers. In this study, we successfully constructed a new EGFR nanobody-based immunotoxin rE/CUS containing cucurmosin (CUS), The immunotoxin was expressed by...
Autores principales: | Deng, Cuimin, Xiong, Jiani, Gu, Xiaofan, Chen, Xiaoying, Wu, Shuifa, Wang, Zhe, Wang, Duanduan, Tu, Jinjin, Xie, Jieming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503554/ https://www.ncbi.nlm.nih.gov/pubmed/28445134 http://dx.doi.org/10.18632/oncotarget.16930 |
Ejemplares similares
-
Novel EGFR-bispecific recombinant immunotoxin based on cucurmosin shows potent anti-tumor efficiency in vitro
por: Zhang, Caiyun, et al.
Publicado: (2021) -
Novel cucurmosin‐based immunotoxin targeting programmed cell death 1‐ligand 1 with high potency against human tumor in vitro and in vivo
por: Zhang, Caiyun, et al.
Publicado: (2020) -
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
por: Narbona, Javier, et al.
Publicado: (2023) -
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022) -
Monitoring extracellular ion and metabolite dynamics with recombinant nanobody-fused biosensors
por: Burgstaller, Sandra, et al.
Publicado: (2022)